维普中文期刊产品整合服务
60篇 您的检索式:作者名="Ruff CT"
    题名 作者 年代 出处 被引量
1Edoxaban versus warfarin in patients with atrial fibrillation显示文摘Giugliano RP Ruff CT Braunwald E 2013N Engl J Med2013,369,22:1
2Ettlcacy and safety of edoxaban for themanagement of elderly patients with atrial fibrillation: ENGAGE AF-TIMI 48 显示文摘Kato ET Giugliano RP Ruff CT 2014Circulation2014,130,16:1
3Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effec- tive aNticoaGulation with factor xA next GEneration in Atrial Fi- briliation-Thrombolysis In Myocardial Infarction study 48 ( EN- GAGE AF-TIMI48)显示文摘RUFF CT GIUGLIANO RP ANTMAN EM 2010Am Heart J2010,160,4:1
4Edoxaban versus warfarin in patients with atrial fibrillation显示文摘Giugliano RP Ruff CT Braunwald E 2013N EnglJ Med2013,369,:1
5Concomitant use of antiplatelet therapy with edoxaban or warfarin in patients with atrial fibrillation in the ENGAGE AF- TIMI 48 trial显示文摘Xu H Ruff CT Giugliano RP 2014Circulation2014,130,19:1
6Edoxaban versus warfarin in patients with atrial fibrillation 显示文摘Giugliano RP Ruff CT Braunwald E 2013N Engl J Med2013,369,22:1
7Edoxaban versus warfarin in patients with atrial fibrillation显示文摘Giugliano RE Ruff CT Braunwald E 2013N Engl J Med2013,369,22:1
8Diagnostic evaluation of theMRP-8/14 for the emergency assessment of chest pain显示文摘Vora AN Bonaca MP Ruff CT 2012JThromb Thrombolysis2012,34,2:1
9Abstract 16612: Efficacy and Safety of Edoxaban for the Man- agement of Elderly Patients With Atrial Fibrillation: Engage AF-TIMI 48 显示文摘Toda Kato E Giugliano RP Ruff CT 2014Circulation2014,130,16:1
10Comparison of the efficacy and safety of new oral anticoagulantswith warfarin in patients with atrial fibrillation: a meta-analysis of ran- domised trials 显示文摘Ruff CT Giugliano liP Braunwald E 2014Lancet2014,383,9921:1
11Edoxaban versus warfarin in patients with atrial fibrillation 显示文摘Giugliano RP Ruff CT Eugene B 2013New Eng- land Journal of Medicine2013,369,22:1
12Edoxaban versus warfarin in patients with atrial fibrillation显示文摘Giugliano RP Ruff CT Braunwald E 2013N Engl J Med2013,369,22:1
13The evolving epidemiology of acute coronary syndromes显示文摘Ruff CT Braunwald E 2011Nat Rev Cardiol2011,8,3:1
14Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials显示文摘Ruff CT Giugliano RP Braunwald E 2014Lancet2014,383,9921:1
15Evaluation of BNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs显示文摘Ruff CT Morrow DA Jarolim P 2011J Rheumatol2011,38,6:1
16Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: de- sign and rationale for the Effective aNticoagulation with factor xA next Genera- Lion in Atrial Fibrillation Thmmbolysis In myocardial Infarction study 48 ( EN- ?-AGE AF-TIMI 48) 显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010,160,4:1
17Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIM1 48) 显示文摘Ruff CT Giugliano RP Antman EM 2010Am Heart J2010,160,4:1
18Will warfarin ever be replaced? 显示文摘Ruff CT Braunwald E 2010J Cardiovasc Pharmacol Ther2010,15,3:1
19Edoxaban versus warfarin in patients with atrial fibrillation显示文摘GIUGLIANO RP RUFF CT BRAUNWALD E eta! 2013N Engl J Med2013,369,22:1
20Edoxaban versus warfarin in patients with atrial fibrillation显示文摘Giugliano RP Ruff CT Braunwald E 2013N Engl J Med2013,369,22:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费